KathleenMMahoneyMD

Hematologic Oncology

Physician

Dr. Mahoney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
330 Brookline Ave
Masco 423
Boston, MA 02215
Phone+1 617-735-2063

Fax+1 617-735-2060

Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2008 - 2011
Uconn School Of MedicineClass of 2008

PubMed

2 citations
Regulation of HHLA2 expression in kidney cancer and myeloid cells.
Tomonari Shigemura, Nahuel Perrot, Zimo Huang, Rupal S Bhatt, Aseman Bagheri Sheshdeh
BMC Cancer. 2023-10-27
17 citations
Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors.
Anthony W Tolcher, Michael Gordon, Kathleen M Mahoney, Anna Seto, Marianna Zavodovskaya
Journal for Immunotherapy of Cancer. 2023-02-01
4 citations
Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights.
Randolph J Noelle, J Louise Lines, Lionel D Lewis, Robert E Martell, Thierry Guillaudeux
Frontiers in Oncology. 2023-01-01

Lectures

A Novel Monoclonal Antibody Combination Plus DC/AML Fusion Vaccine Eradicates AML in an Immunocompetent Murine Model
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

The Kidney Cancer Association Announces Recipients for the Advanced Discovery Awards (ADA) and Young Investigator Awards (YIA)September 16th, 2019
Cancer Survivor Rides to Help Beth Israel-Deaconess TeamSeptember 7th, 2018